Has Blaine Farless, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,400 in general payments to Blaine Farless, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Blaine Farless, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Blaine Farless, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Blaine Farless, MD

Orthopaedic Surgery · Cleburne, TXNPI 1881633766

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,545 of the $3,400 with a category attached, or 74.9%. 26 manufacturers reported payments, led by Arthrex at 32.5% of the total. Reporting peaked in 2024 at $1,986 and has fallen 83.8% since, to $321 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in TX, where the typical reported total is $4,671.

$3,400in general payments, 2019–2025

Across 82 payments — averaging $41.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$1K
Pylant Medical$611
Johnson & Johnson$251
AbbVie$242
Stryker$205
Ferring Pharmaceuticals Inc.$138
plus $848 from 20 others

What the payments were for

Travel & lodging$85525%
Food & beverage$2,54575%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	17	$1,105
Pylant Medical	5	$611
Johnson & Johnson(2 entities)	6	$251
AbbVie	7	$242
Stryker	4	$205
Ferring Pharmaceuticals Inc.	8	$138
Medical Device Business Services, Inc.	1	$127
GRT US Holding, Inc.	3	$90
Highridge Medical LLC	1	$88
Pacira Pharmaceuticals Incorporated	4	$75
Pacira Therapeutics, Inc.	3	$72
Abbott	3	$54
Amgen	2	$43
Bioventus LLC	2	$43
Smith+Nephew	2	$33
Integra Lifesciences Corporation	2	$32
Boston Scientific	1	$28
Rayner Intraocular Lenses Limited	2	$27
Acell, Inc.	1	$24
Baxter Healthcare	1	$22
Zimmer Biomet	1	$20
Heraeus Medical, LLC.	2	$17
Fidia Pharma USA Inc.	1	$15
Pfizer	1	$15
Merck	1	$13
Vericel Corporation	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,400 in reported general payments places this provider in the 40th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$176,540

Medicare patients

258

Services billed

6,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	236	$3,094
Cyclobenzaprine Hcl	90	$1,329
Gabapentin	127	$1,248
Celecoxib	26	$621
Ondansetron OdtOndansetron	40	$570
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	30	$524
Ketorolac Tromethamine	29	$442
Acetaminophen-CodeineAcetaminophen With Codeine	33	$317
Meloxicam	57	$188
Tramadol Hcl	31	$125
Furosemide	11	$27
Diclofenac Sodium	12	$5

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Cleburne

Stephen BurkhartSan Antonio$185.3M
Kirby HittTemple$9.1M
Robert GrahamAustin$6.3M
Richard JonesDallas$6.3M
Stefan KreuzerHouston$6.2M
Michael WirthSan Antonio$4.5M
Stephen IncavoHouston$4.3M
Thomas EdwardsHouston$4.1M
James BrodskyDallas$2.5M
Robert SchmidtFort Worth$2M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →